Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Deray

Showing results (171-180 of 213) with videos related to

Pageof 22
Sort By:
AIDS (London, England)|April 21, 2004
Renal safety of tenofovir in HIV treatment-experienced patientsHassane Izzedine, Corinne Isnard-Bagnis, Jean Sébastien Hulot, et al.
Cancer|April 17, 2014
Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patientsVincent Launay-Vacher, Sarah Zimner-Rapuch, Nicolas Poulalhon, et al.
American Journal of Nephrology|January 12, 2017
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative ReviewRimda Wanchoo, Sabine Karam, Nupur N Uppal, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2017
APOL1 variants may induce HIV-associated nephropathy during HIV primary infectionMarine De Laroche, Geoffroy Desbuissons, Philippe Rouvier, et al.
The Journal of Infectious Diseases|November 4, 2006
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathyHassane Izzedine, Jean-Sebastien Hulot, Eric Villard, et al.
Heart (British Cardiac Society)|June 25, 2014
Iron deficiency: an emerging therapeutic target in heart failureAlain Cohen-Solal, Christophe Leclercq, Gilbert Deray, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2006
Renal outcome after ciclosporin-induced nephrotoxicityIsabelle Tostivint, Sophie Tezenas du Montcel, Marie Chantal Jaudon, et al.
Blood Purification|January 31, 2002
Detection of vascular access stenosis by measurement of access blood flow from ionic dialysanceLucile Mercadal, Emmanuel Challier, Philippe Cluzel, et al.
Journal of the American Society of Nephrology : JASN|November 22, 2002
Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up studyCorinne Isnard Bagnis, Sophie Tezenas du Montcel, Hélène Beaufils, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2011
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe studyMarc Spielmann, Elisabeth Luporsi, Isabelle Ray-Coquard, et al.
Pageof 22

Showing results (171-180 of 213) with videos related to

Sort By:
Pageof 22
AIDS (London, England)|April 21, 2004
Renal safety of tenofovir in HIV treatment-experienced patientsHassane Izzedine, Corinne Isnard-Bagnis, Jean Sébastien Hulot, et al.
Cancer|April 17, 2014
Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patientsVincent Launay-Vacher, Sarah Zimner-Rapuch, Nicolas Poulalhon, et al.
American Journal of Nephrology|January 12, 2017
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative ReviewRimda Wanchoo, Sabine Karam, Nupur N Uppal, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2017
APOL1 variants may induce HIV-associated nephropathy during HIV primary infectionMarine De Laroche, Geoffroy Desbuissons, Philippe Rouvier, et al.
The Journal of Infectious Diseases|November 4, 2006
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathyHassane Izzedine, Jean-Sebastien Hulot, Eric Villard, et al.
Heart (British Cardiac Society)|June 25, 2014
Iron deficiency: an emerging therapeutic target in heart failureAlain Cohen-Solal, Christophe Leclercq, Gilbert Deray, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2006
Renal outcome after ciclosporin-induced nephrotoxicityIsabelle Tostivint, Sophie Tezenas du Montcel, Marie Chantal Jaudon, et al.
Blood Purification|January 31, 2002
Detection of vascular access stenosis by measurement of access blood flow from ionic dialysanceLucile Mercadal, Emmanuel Challier, Philippe Cluzel, et al.
Journal of the American Society of Nephrology : JASN|November 22, 2002
Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up studyCorinne Isnard Bagnis, Sophie Tezenas du Montcel, Hélène Beaufils, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2011
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe studyMarc Spielmann, Elisabeth Luporsi, Isabelle Ray-Coquard, et al.
Pageof 22